Clinical Trial Update: Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial [Phase 3]

View source ↗

Summary

A Phase 3 trial (IRIS-trial) is evaluating iron administration to improve recovery after surgery with blood loss and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm
• Liver Cancer
• Liver Metastases
• Pancreatic Cancer

Drugs mentioned

• Iron supplement

Snippet

Sponsor: Jon Unosson | Conditions: Surgery, Liver Metastases | Phase 3 | Status: RECRUITING